2020
DOI: 10.3389/fneur.2020.598650
|View full text |Cite
|
Sign up to set email alerts
|

A Case Report of Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Diagnosed After Long Term Diagnosis of Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids

Abstract: Cases of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy who were initially diagnosed with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) were rarely reported. Herein, we reported a 31-year-old woman who presented with 7 years of recurrent headache. Her clinical history, symptoms, brain MRI enhancement features, and response to treatment during each attack were reviewed. Her brain MRI 7 years ago demonstrated characteristic pepper-like … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 6 publications
0
7
0
Order By: Relevance
“…These patients were similar to our own in that characteristic enhancement was revealed after initially unremarkable MRI findings, but their clinical courses involved relapse and remission or were insidious. Some patients with GFAP-A experience relapses ( 9 ) or chronic progression ( 10 , 11 ), but this is not common for GFAP-A. Our patient showed an acute meningoencephalitis-like disease course, which is representative of GFAP-A, and characteristic enhancement was observed even after intravenous methylprednisolone therapy in the acute phase.…”
Section: Discussionmentioning
confidence: 59%
See 1 more Smart Citation
“…These patients were similar to our own in that characteristic enhancement was revealed after initially unremarkable MRI findings, but their clinical courses involved relapse and remission or were insidious. Some patients with GFAP-A experience relapses ( 9 ) or chronic progression ( 10 , 11 ), but this is not common for GFAP-A. Our patient showed an acute meningoencephalitis-like disease course, which is representative of GFAP-A, and characteristic enhancement was observed even after intravenous methylprednisolone therapy in the acute phase.…”
Section: Discussionmentioning
confidence: 59%
“…Since we did not strongly suspect that he had GFAP-A at first, we did not check for antibodies on admission. Previously, a 31-year-old woman who had been receiving oral corticosteroids for 7 years, and initially been diagnosed with chronic lymphocytic inflammation with pontine perivascular enhancement-responsive lesions was reevaluated at the time of the seventh relapse, when haracteristic gadolinium enhancement of GFAP-A was first observed ( 9 ). Furthermore, a rapidly progressive demented 54-year-old man whose symptoms mimicked Creuzfeldt-Jakob disease was confirmed to have GFAP-A at six months from the first brain MRI ( 10 ).…”
Section: Discussionmentioning
confidence: 99%
“…In this report, we present a unique fatal case of a briefly observed clinical history of a patient as well as repeated MRI with several atypical features fulfilling revised criteria for CLIPPERS [12] . The young woman did not have typical manifestations of subacute pontocerebellar dysfunction, such as gait ataxia and diplopia.…”
Section: Discussionmentioning
confidence: 99%
“…It has been proposed that a relapse with atypical symptoms or radiological features should be a “red flag” suggestive of a diagnosis of CLIPPERS [12] . Our patient showed an extreme and unusual discrepancy between the clinical and radiological findings, which caused us to revise the diagnosis by additional MRI quantitative techniques.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation